Diabetes medication to reduce heart disease shows promise
Empagliflozin is a medication that falls under a category of drugs called SGLT2 inhibitors, which lower blood sugar.
Empagliflozin is a medication that falls under a category of drugs called SGLT2 inhibitors, which lower blood sugar.
